| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 174.358.222 $ | 98,99 | 4.935.934 | |||||||
| Revolution Medicines Inc | Revolution Medicines Inc | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 13.614.146 $ | 7,73 | 86.450 | |
| Eli Lilly & Co | Eli Lilly & Co | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 8.490.820 $ | 4,82 | 7.684 | |
| Roche Holding AG | Roche Holding AG | EC | 771195104 | Long | Börsenkurs (Stufe 1) | 7.422.617 $ | 4,21 | 141.653 | |
| Cogent Biosciences Inc | Cogent Biosciences Inc | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 7.216.408 $ | 4,10 | 206.419 | |
| Novartis AG | Novartis AG | EC | CH0012005267 | Long | Börsenkurs (Stufe 1) | 7.097.427 $ | 4,03 | 47.020 | |
| Immunome Inc | Immunome Inc | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 6.890.596 $ | 3,91 | 315.648 | |
| Celcuity Inc | Celcuity Inc | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 6.305.156 $ | 3,58 | 47.450 | |
| Merck & Co Inc | Merck & Co Inc | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 6.289.548 $ | 3,57 | 52.978 | |
| AstraZeneca PLC | AstraZeneca PLC | EC | GB0009895292 | Long | Börsenkurs (Stufe 1) | 6.226.848 $ | 3,54 | 33.501 | |
| Nuvalent Inc | Nuvalent Inc | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 5.934.898 $ | 3,37 | 53.763 | |
| Bristol-Myers Squibb Co | Bristol-Myers Squibb Co | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 5.814.062 $ | 3,30 | 101.680 | |
| Legend Biotech Corp | Legend Biotech Corp | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 5.271.539 $ | 2,99 | 194.092 | |
| AbbVie Inc | AbbVie Inc | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 4.942.244 $ | 2,81 | 22.700 | |
| Exelixis Inc | Exelixis Inc | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 4.890.755 $ | 2,78 | 96.885 | |
| Bridgebio Pharma Inc | Bridgebio Pharma Inc | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 4.849.636 $ | 2,75 | 73.191 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 4.484.067 $ | 2,55 | 19.900 | |
| CG oncology Inc | CG oncology Inc | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 4.279.448 $ | 2,43 | 68.702 | |
| Genmab A/S | Genmab A/S | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 4.182.810 $ | 2,37 | 158.861 | |
| Ideaya Biosciences Inc | Ideaya Biosciences Inc | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 4.003.411 $ | 2,27 | 135.847 | |
| Amgen Inc | Amgen Inc | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 3.711.089 $ | 2,11 | 11.019 | |
| Zai Lab Ltd | Zai Lab Ltd | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 3.484.435 $ | 1,98 | 196.972 | |
| BeOne Medicines Ltd | BeOne Medicines Ltd | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 3.312.520 $ | 1,88 | 11.505 | |
| Zymeworks Inc | Zymeworks Inc | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 2.654.105 $ | 1,51 | 105.615 | |
| Enliven Therapeutics Inc | Enliven Therapeutics Inc | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 2.302.855 $ | 1,31 | 58.197 | |
| Relay Therapeutics Inc | Relay Therapeutics Inc | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 2.263.118 $ | 1,28 | 161.076 | |
| Halozyme Therapeutics Inc | Halozyme Therapeutics Inc | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 2.169.071 $ | 1,23 | 32.598 | |
| Summit Therapeutics Inc | Summit Therapeutics Inc | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 2.124.041 $ | 1,21 | 121.097 | |
| Arcus Biosciences Inc | Arcus Biosciences Inc | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 2.106.768 $ | 1,20 | 83.140 | |
| Gilead Sciences Inc | Gilead Sciences Inc | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 1.975.046 $ | 1,12 | 14.692 | |
| Immatics NV | Immatics NV | EC | NL0015285941 | Long | Börsenkurs (Stufe 1) | 1.973.953 $ | 1,12 | 171.499 | |
| Erasca Inc | Erasca Inc | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 1.898.112 $ | 1,08 | 147.828 | |
| Nuvation Bio Inc | Nuvation Bio Inc | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 1.889.596 $ | 1,07 | 395.313 | |
| AnaptysBio Inc | AnaptysBio Inc | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 1.740.801 $ | 0,99 | 31.270 | |
| UroGen Pharma Ltd | UroGen Pharma Ltd | EC | IL0011407140 | Long | Börsenkurs (Stufe 1) | 1.646.111 $ | 0,93 | 58.518 | |
| Guardant Health Inc | Guardant Health Inc | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 1.424.774 $ | 0,81 | 10.986 | |
| Syndax Pharmaceuticals Inc | Syndax Pharmaceuticals Inc | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 1.414.633 $ | 0,80 | 72.212 | |
| Corvus Pharmaceuticals Inc | Corvus Pharmaceuticals Inc | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 1.346.200 $ | 0,76 | 108.477 | |
| Regeneron Pharmaceuticals Inc | Regeneron Pharmaceuticals Inc | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 1.314.400 $ | 0,75 | 2.138 | |
| ArriVent Biopharma Inc | ArriVent Biopharma Inc | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 1.293.861 $ | 0,73 | 42.744 | |
| Chugai Pharmaceutical Co Ltd | Chugai Pharmaceutical Co Ltd | EC | JP3519400000 | Long | Börsenkurs (Stufe 1) | 1.174.249 $ | 0,67 | 23.697 | |
| Iovance Biotherapeutics Inc | Iovance Biotherapeutics Inc | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 1.148.197 $ | 0,65 | 280.048 | |
| Inhibrx Biosciences Inc | Inhibrx Biosciences Inc | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 1.057.782 $ | 0,60 | 10.170 | |
| Olema Pharmaceuticals Inc | Olema Pharmaceuticals Inc | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 1.052.021 $ | 0,60 | 79.759 | |
| Cullinan Therapeutics Inc | Cullinan Therapeutics Inc | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 1.032.859 $ | 0,59 | 62.826 | |
| Natera Inc | Natera Inc | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 946.642 $ | 0,54 | 4.238 | |
| First Tracks Biotherapeutics I | First Tracks Biotherapeutics Inc | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 932.367 $ | 0,53 | 58.419 | |
| Immunocore Holdings PLC | Immunocore Holdings PLC | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 891.228 $ | 0,51 | 30.849 | |
| BridgeBio Oncology Therapeutic | BridgeBio Oncology Therapeutics Inc | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 837.251 $ | 0,48 | 93.339 | |
| CytomX Therapeutics Inc | CytomX Therapeutics Inc | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 824.353 $ | 0,47 | 228.987 | |
| HUTCHMED China Ltd | HUTCHMED China Ltd | EC | 44842L103 | Long | Börsenkurs (Stufe 1) | 776.573 $ | 0,44 | 67.823 | |
| Arvinas Inc | Arvinas Inc | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 755.434 $ | 0,43 | 84.124 | |
| Janux Therapeutics Inc | Janux Therapeutics Inc | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 751.706 $ | 0,43 | 51.522 | |
| Adlai Nortye Ltd | Adlai Nortye Ltd | EC | 00704R109 | Long | Börsenkurs (Stufe 1) | 529.587 $ | 0,30 | 44.354 | |
| Tyra Biosciences Inc | Tyra Biosciences Inc | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 527.210 $ | 0,30 | 15.780 | |
| ORIC Pharmaceuticals Inc | ORIC Pharmaceuticals Inc | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 489.906 $ | 0,28 | 57.977 | |
| SELLAS Life Sciences Group Inc | SELLAS Life Sciences Group Inc | EC | 81642T209 | Long | Börsenkurs (Stufe 1) | 378.936 $ | 0,22 | 40.702 | |
| 174.358.222 $ | 98,99 | 4.935.934 |